11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply
- Contribution to journal › Letter
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
- Contribution to journal › Article
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
- Contribution to journal › Article
-
Mark
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients : a cohort study
- Contribution to journal › Article
- 2023
-
Mark
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial
- Contribution to journal › Article
-
Mark
Association between high-sensitivity C-reactive protein and coronary atherosclerosis in a general middle-aged population
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
- Contribution to journal › Article
-
Mark
Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
- Contribution to journal › Article
-
Mark
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
- Contribution to journal › Article
